Skip to main content
logo
Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
13.60
+0.82 (6.38%)
At close: Jul 25, 2025, 4:00 PM
13.55
-0.04 (-0.33%)
After-hours: Jul 25, 2025, 7:51 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Genome Editing-based Therapies
57.88M
Log In
Log In
Log In
Log In
Upgrade
Genome Editing-based Therapies Growth
59.55%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
57.88M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
59.55%
Log In
Log In
Log In
Log In
Upgrade